New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 16, 2014
09:14 EDTTGTXTG Therapeutics price target raised to $20 from $15 at Roth Capital
Roth Capital increased its price target on TG Therapeutics after the company announced data for its TG-1101 & ibrutinib combination in r/r CLL or MCL. The firm was quite impressed by the data and reiterates a Focus Pick rating on the shares.
News For TGTX From The Last 14 Days
Check below for free stories on TGTX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for TGTX

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use